These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33268682)

  • 21. Prophylactic Effect of Premedication with Intravenous Magnesium on Renal Dysfunction in Preoperative Cisplatin-Based Chemotherapy for Esophageal Cancer.
    Kubo Y; Miyata H; Sugimura K; Shinno N; Ushigome H; Yanagimoto Y; Takahashi Y; Yamamoto K; Nishimura J; Wada H; Takahashi H; Yasui M; Omori T; Ohue M; Yano M
    Oncology; 2019; 97(6):319-326. PubMed ID: 31553989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Chemotherapy Regimen Management Practice by Oncology-Specialized and Non-specialized Pharmacists Collaboration.
    Saito Y; Uchiyama K; Sakamoto T; Kubota K; Oki H; Iwai M; Takekuma Y; Komatsu Y; Sugawara M
    Biol Pharm Bull; 2021; 44(3):293-297. PubMed ID: 33642541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
    Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
    J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.
    Kitada N; Takara K; Minegaki T; Itoh C; Tsujimoto M; Sakaeda T; Yokoyama T
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):577-84. PubMed ID: 18030470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of lycopene against cisplatin-induced acute renal injury in rats: organic anion and cation transporters evaluation.
    Erman F; Tuzcu M; Orhan C; Sahin N; Sahin K
    Biol Trace Elem Res; 2014 Apr; 158(1):90-5. PubMed ID: 24531880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydration with 15 mEq Magnesium Is Effective at Reducingthe Risk for Cisplatin-induced Nephrotoxicity in Patients Receiving Cisplatin (≥50 mg/m2) Combination Chemotherapy.
    Yamamoto Y; Watanabe K; Tsukiyama I; Yabushita H; Matsuura K; Wakatsuki A
    Anticancer Res; 2016 Apr; 36(4):1873-7. PubMed ID: 27069173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of outpatient interventions made at an ambulatory cancer centre oncology pharmacy in Singapore.
    Chew C; Chiang J; Yeoh TT
    J Oncol Pharm Pract; 2015 Apr; 21(2):93-101. PubMed ID: 24477774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex and age differences related to renal OCT2 gene expression in cisplatin-induced nephrotoxicity.
    El-Arabey AA
    Iran J Kidney Dis; 2015 Jul; 9(4):335-6. PubMed ID: 26174463
    [No Abstract]   [Full Text] [Related]  

  • 29. Cisplatin-induced nephrotoxicity in patients with advanced neuroblastoma.
    Yanagisawa R; Kubota N; Hidaka E; Sakashita K; Tanaka M; Nakazawa Y; Nakamura T
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27253. PubMed ID: 29797635
    [No Abstract]   [Full Text] [Related]  

  • 30. Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury.
    Matsuzaki T; Morisaki T; Sugimoto W; Yokoo K; Sato D; Nonoguchi H; Tomita K; Terada T; Inui K; Hamada A; Saito H
    Drug Metab Dispos; 2008 Apr; 36(4):649-54. PubMed ID: 18180268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sharing Patient Safety Management Skills in Oncology Pharmaceutical Outpatient Service].
    Kawakami K
    Yakugaku Zasshi; 2023; 143(3):217-221. PubMed ID: 36858551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the pharmacist in the multidisciplinary approach to the prevention and resolution of drug-related problems in cancer chemotherapy.
    Boşnak AS; Birand N; Diker Ö; Abdi A; Başgut B
    J Oncol Pharm Pract; 2019 Sep; 25(6):1312-1320. PubMed ID: 29984626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Magnesium premedication prevents Cisplatin-induced nephrotoxicity in patients with esophageal and hypopharyngeal cancer].
    Hirai S; Kaida S; Ito T; Hasebe S; Ueno M; Udagawa H; Hayashi M
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):743-7. PubMed ID: 23863650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation and evaluation of medicine and therapeutic information service by clinical pharmacists in oncology care setting.
    Patel H; Gurumurthy P
    J Oncol Pharm Pract; 2019 Jan; 25(1):60-67. PubMed ID: 28841101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effect of atenolol on urinary excretion of metformin via down-regulating multidrug and toxin extrusion protein 1 (rMate1) expression in the kidney of rats.
    Ma YR; Huang J; Shao YY; Ma K; Zhang GQ; Zhou Y; Zhi R; Qin HY; Wu XA
    Eur J Pharm Sci; 2015 Feb; 68():18-26. PubMed ID: 25486332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Amifostine as protective agent in cisplatin-based chemotherapy of advanced bladder cancer].
    Heidenreich A; Marx FJ; Peters HJ
    Urologe A; 1999 Nov; 38(6):586-91. PubMed ID: 10591805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: a retrospective study.
    Yoshida T; Niho S; Toda M; Goto K; Yoh K; Umemura S; Matsumoto S; Ohmatsu H; Ohe Y
    Jpn J Clin Oncol; 2014 Apr; 44(4):346-54. PubMed ID: 24503028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the toxicity and transport mechanisms of cisplatin in kidney tissues in comparison to a gold-based cytotoxic agent.
    Spreckelmeyer S; Estrada-Ortiz N; Prins GGH; van der Zee M; Gammelgaard B; Stürup S; de Graaf IAM; Groothuis GMM; Casini A
    Metallomics; 2017 Dec; 9(12):1786-1795. PubMed ID: 29104982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane transporters as mediators of cisplatin side-effects.
    Ciarimboli G
    Anticancer Res; 2014 Jan; 34(1):547-50. PubMed ID: 24403515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual function of OCT2 and MATE1 in cisplatin induced nephrotoxicity.
    El-Arabey AA
    Pharmacol Res; 2017 May; 119():493. PubMed ID: 27890551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.